Royal Bank of Canada
DWTX

Royal Bank of Canada’s Dogwood Therapeutics DWTX Stock Holding History

Royal Bank of Canada’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed – – 7593
2024
Q2 		$0 Hold
2
– – ﹤0.01% 7637
2024
Q1 		$0 Hold
2
– – ﹤0.01% 7713
2023
Q4 		$0 Hold
2
– – ﹤0.01% 7681
2023
Q3 		$0 Sell
2
-7
-78% -$243 ﹤0.01% 7704
2023
Q2 		$0 Buy
+9
New +$257 ﹤0.01% 7736
2022
Q4 		– Sell
-1
Closed – – 7820
2022
Q3 		$0 Buy
+1
New +$141 ﹤0.01% 7959
2021
Q4 		– Sell
-40
Closed -$5K – 7949
2021
Q3 		$5K Buy
+40
New +$5.53K ﹤0.01% 7151

Other funds holding DWTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's DWTX Position: Q3 2024 in Review

Royal Bank of Canada sold out of Dogwood Therapeutics (DWTX) in Q3 2024, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in DWTX in Q3 2021 and held it in 7 quarters. The position peaked at $5K in Q3 2021. 24 funds tracked by Wall St. Rank hold DWTX as of Q3 2024.

  • Royal Bank of Canada reported no remaining Dogwood Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Dogwood Therapeutics shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Dogwood Therapeutics in Q3 2021 and held it in 7 quarters.
  • Royal Bank of Canada's Dogwood Therapeutics position peaked at $5K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.